Reduced Haloperidol
Reduced Haloperidol (Haloperidol metabolite II) is an antipsychotic compound with neurotransmitter modulating activity. Reduced Haloperidol is commonly used to inhibit schizophrenia and other psychotic disorders. Reduced Haloperidol helps reduce the occurrence of hallucinations and delusions by inhibiting the activity of dopamine receptors.
Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.
- CAS. Nr.: 34104-67-1
- Formel: C21H25ClFNO2
- Molecular Weight:377.88
-
Speicherung:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biologische Aktivität
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| LNCaP | IC50 |
177 μM
Compound: Haloperidol metabolite II
|
Antiproliferative activity against human LNCAP cells after 24 hrs by MTT assay
Antiproliferative activity against human LNCAP cells after 24 hrs by MTT assay
|
[PMID: 21055848] |
| PC-3 | IC50 |
208 μM
Compound: Haloperidol metabolite II
|
Antiproliferative activity against human PC3 cells after 24 hrs by MTT assay
Antiproliferative activity against human PC3 cells after 24 hrs by MTT assay
|
[PMID: 21055848] |
Chemical Information
-
CAS. Nr. 34104-67-1
-
Molecular Weight 377.88
-
Formel C21H25ClFNO2
-
SMILES
FC1=CC=C(C(CCCN2CCC(C3=CC=C(C=C3)Cl)(CC2)O)O)C=C1
-
Synonyms
Haloperidol metabolite II
-
Versand
Room temperature in continental US; may vary elsewhere.
-
Speicherung
Please store the product under the recommended conditions in the Certificate of Analysis.
Reinheit & Dokumentation
Verweise
Calculators
Konzentration (Stammlösung) × Volumen (Stammlösung) = Konzentration (Ziellösung) × Volumen (Ziellösung)